Pruritus Therapeutics Market Size, Share & Growth Forecast 2025
According to a new report from Intel Market Research , global pruritus therapeutics market was valued at USD 13.5 billion in 2024 and is projected to reach USD 18.04 billion by 2032 , exhibiting a steady CAGR of 4.3% during the forecast period (2025-2032). This sustained expansion is propelled by the escalating global burden of chronic itchy skin conditions, increased diagnostic capabilities, and a surge in novel targeted therapies that offer superior efficacy and safety profiles. What is Pruritus Therapeutics? Pruritus therapeutics are pharmaceutical interventions designed to treat the sensation of itching, a debilitating symptom associated with a wide spectrum of conditions, from atopic dermatitis and psoriasis to systemic diseases like chronic kidney disease and cholestatic liver disorders. These treatments specifically target the complex neuroimmune pathways responsible for itch, which involve a cascade of chemical mediators including histamine, interleukins (such as IL-31...